Last reviewed · How we verify
NCT03855644: PBM
Blood Transfusion Among Patients With Pelvic Fracture in China
trial in Pelvic Fracture in 2,000 participants. Status unknown.
1 August 2019
Quick facts
| Lead sponsor | The Third Xiangya Hospital of Central South University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 5 April 2019 |
| Primary completion | 1 August 2019 |
| Estimated completion | 1 September 2019 |
| Sites | 1 location across China |
Conditions studied
- Pelvic Fracture — all drugs for Pelvic Fracture →
- Transfusion Reaction — all drugs for Transfusion Reaction →
- Blood Transfusion Complication — all drugs for Blood Transfusion Complication →
Sponsor
The Third Xiangya Hospital of Central South University
Who can join
Adults 1 to 80, any sex, with Pelvic Fracture or Transfusion Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to the patient's blood management concept, this study intends to collect basic information, surgical data, blood transfusion related data and patient prognosis data of patients with pelvic fractures, and to construct a predictive model of intraoperative blood transfusion in patients with pelvic fractures by multiple linear regression analysis. To guide physicians use blood accurately during surgery. Prompt doctors to reduce blood transfusion dose and improve patient prognosis by stopping bleeding and blood recovery before surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ability of a Machine Learning Algorithm to Predict the Need for Perioperative Red Blood Cells Transfusion in Pelvic Fracture Patients: A Multicenter Cohort Study in China.
Huang X, Wang Y, Chen B, Huang Y, et al · · 2021 · cited 12× · PMID 34485333 · DOI 10.3389/fmed.2021.694733
Verify or expand the search:
- PubMed search for NCT03855644
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Fracture
Currently open trials in the same condition.
- NCT06054165 — Impact of a Clinical Pathway for Pelvic Fragility Fractures · NA · recruiting
- NCT05367505 — Titanium Fusion Implant in Combination With Trans-iliac Screws for Insufficiency Fractures of the Pelvis · NA · recruiting
- NCT04937868 — Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients · recruiting
Other The Third Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07353307 — A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia Afte · Phase 3 · recruiting
- NCT07123207 — Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Dis · NA · recruiting
- NCT07034664 — IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study · recruiting
- NCT07093294 — Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter · recruiting
- NCT07039097 — A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resectio · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03855644 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Xiangya Hospital of Central South University
- Last refreshed: 27 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03855644.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing